Note: Report updated on 15 Sept 2021 with removal of reference to the average price of antigen RDTs on page 3, removal of reference to price reductions in diagnostics on page 4, and the addition of references to US$ 202m in funding for in-country vaccine delivery on pages 2 and 8.
Update: the Q3 2021 Quarterly Update can be found here.
